D-0600-2024 Class II Terminated
FDA drug recall D-0600-2024 was initiated by Zydus Pharmaceuticals (USA) Inc on Jun 27, 2024 and is designated Class II. Reason for recall: Presence of particulate matter: glass The recall status is terminated (terminated Sep 4, 2025). Affected quantity: 432250 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Jul 24, 2024
- Initiation Date
- Jun 27, 2024
- Termination Date
- Sep 4, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 432250 vials
Product Description
Cyanocobalamin Injection, USP, 1,000mcg/mL, 1 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN, 38141, Mfd. in India, NDC 16714-165-01.
Reason for Recall
Presence of particulate matter: glass
Distribution Pattern
TN
Code Information
Lot #: L200253, L200281, L200301, Exp 07/31/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0600-2024
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 26, 2026